ORBITAL THERAPEUTICS
LIVE

Serial Number

98597164

Owner

Orbital Therapeutics, Inc.

Attorney

Marilyn F. Kelly

Filing Date

Jun 12, 2024

Add to watchlist:

No watchlists yet
View on USPTO

ORBITAL THERAPEUTICS Trademark

Serial Number: 98597164

ORBITAL THERAPEUTICS is a trademark filed by Orbital Therapeutics, Inc. on June 12, 2024. The trademark is classified under Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). The application is currently pending registration.

Owner Contact Info

Orbital Therapeutics, Inc. (4 trademarks)

100 Binney Street, Floor 4
Cambridge, MA 02142

Entity Type: 03

Trademark Details

Filing Date

June 12, 2024

Registration Date

Not Registered

Published for Opposition

March 11, 2025

Goods & Services

Research and development in the biotechnology field; Consulting services in the fields of biotechnology and genetic science; Development of new technology for others in the fields of genomics and biotechnology; Providing laboratory research services in the field of gene expression or RNA-based therapeutics; Testing, inspection, research, or development of chemical and biotechnology preparations; Scientific research in the fields of pharmaceuticals, vaccines, medicine, biologics, biotherapeutics, biosimilars and therapeutics; Design, engineering, research, development and testing services in the field of protein-encoding nucleic acids and polypeptide-encoding nucleic acids; Providing information on the subject of scientific and medical research in the fields of biotechnology, biologics, biosimilars, pharmaceuticals, vaccines, and therapeutics related to genetic science, genomics, gene expression, protein-encoding nucleic acids or polypeptide-encoding nucleic acids

Pharmaceutical preparations for the prevention and treatment of diseases and disorders related to the immune system, autoimmune diseases and disorders, cancer, oncology indications, or hematologic disorders; Pharmaceutical preparations in the nature of protein-based therapeutics for the treatment of diseases and disorders related to the immune system, autoimmune diseases and disorders, cancer, oncology indications, or hematologic disorders; Therapeutic and preventative vaccines; Medical, biological and pharmaceutical preparations containing polypeptide encoding nucleic acids for the prevention and treatment of infectious diseases and disorders, immunologic disorders, oncology indications, or hematologic disorders; RNA-based therapeutics for the treatment and prevention of infectious diseases and disorders, immunologic disorders, oncology indications, or hematologic disorders; Therapeutic agents for the treatment of diseases and disorders related to the immune system, autoimmune diseases and disorders, cancer, oncology indications, or hematologic disorders

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 28, 2026 EXRA
SOU EXTENSION 2 GRANTED
Apr 27, 2026 EX2G
SOU EXTENSION 2 FILED
Apr 27, 2026 EXT2
SOU TEAS EXTENSION RECEIVED
Apr 27, 2026 EEXT
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 14, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 14, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 14, 2026 REAP
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Apr 8, 2026 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Apr 8, 2026 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 8, 2026 REAP
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 17, 2025 EXRA
SOU EXTENSION 1 GRANTED
Sep 16, 2025 EX1G
SOU EXTENSION 1 FILED
Sep 16, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
Sep 16, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
May 6, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Mar 11, 2025 NPUB
PUBLISHED FOR OPPOSITION
Mar 11, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Mar 5, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Feb 14, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 13, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 13, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 13, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Dec 18, 2024 GNRN
NON-FINAL ACTION E-MAILED
Dec 18, 2024 GNRT
NON-FINAL ACTION WRITTEN
Dec 18, 2024 CNRT
ASSIGNED TO EXAMINER
Dec 18, 2024 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
Aug 15, 2024 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Aug 13, 2024 NWOS
NEW APPLICATION ENTERED
Jun 12, 2024 NWAP